|Articles|August 1, 2002

Agreement announced: InSite Vision to help find test for PCG detection

Alameda, CA-InSite Vision Inc. has joined forces with an unnamed diagnostics company to develop a commercial assay to detect genetic mutations associated with primary congenital glaucoma (PCG).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Latest CME